Canada Approves Celltrion’s Remsima SC Biosimilar

Company Plans to Expand From Initial RA Indication To Also Cover IBD

 
• By Akriti Seth
Canada Flag
Celltrion receives Health Canada approval for its subcutaneous version of Remsima • Source: Shutterstock

More from Biosimilars

More from Products